title: Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap.
authors.affiliation: MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK. andrew.nunn@ucl.ac.uk.
authors.forename: Andrew
authors.initials: A
authors.lastname: Nunn
authors.affiliation: MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.
authors.forename: Conor
authors.initials: C
authors.lastname: Tweed
mesh_terms: D000995:Antitubercular Agents; D006801:Humans; D009169:Mycobacterium tuberculosis; D012293:Rifampin; D018088:Tuberculosis, Multidrug-Resistant
chemical_list: D000995:Antitubercular Agents; D012293:Rifampin